When selecting an HLA mismatched stem cell donor consider donor immune status

Area of Science:

• Immunology
• Transplantation Biology
• Hematology

Background:

• Hematopoietic stem cell (HSC) transplantation relies heavily on Human Leukocyte Antigen (HLA) matching.
• Many patients struggle to find a suitable HLA-identical donor, limiting treatment options.
• Maternal microchimerism and fetal antigen exposure can influence immune tolerance.

Purpose of the Study:

• To explore the potential of utilizing HLA mismatched grafts in HSC transplantation.
• To investigate the role of donor alloimmune status, influenced by maternal microchimerism, in graft acceptance.
• To offer alternative donor selection strategies for patients without HLA-identical siblings.

Main Methods:

• Analysis of maternal microchimerism and its impact on donor immune tolerance.
• Evaluation of fetal antigen exposure and maternal immune responses (immunization vs. tolerance).
• Assessment of alloimmune status in potential HSC donors.

Main Results:

• Maternal microchimeric cells and molecules can induce long-lasting T regulatory cells in donors.
• Maternal immune responses to fetal antigens vary, including immunization and tolerance.
• Donor alloimmune status presents a novel factor for consideration in HSC donor selection.

Conclusions:

• Considering the donor's alloimmune status, particularly regarding maternal microchimerism, is a promising strategy.
• HLA mismatched grafts can be a viable alternative when HLA-identical donors are unavailable.
• This approach may expand donor pool accessibility for HSC transplantation.